Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-03-01
2005-03-01
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S007400
Reexamination Certificate
active
06861411
ABSTRACT:
The invention features methods and compositions for treating ocular infections. The method comprises topically administering to an eye of an animal in need of such treatment an ocular infection-treating amount of azithromycin.
REFERENCES:
patent: 4474768 (1984-10-01), Bright
patent: 4512982 (1985-04-01), Hauske et al.
patent: 4551456 (1985-11-01), Katz
patent: 4692454 (1987-09-01), Mich et al.
patent: 4851415 (1989-07-01), Mich et al.
patent: 5250518 (1993-10-01), Kobrehel et al.
patent: 5441939 (1995-08-01), Yang
patent: 5498699 (1996-03-01), Djokic et al.
patent: 5605889 (1997-02-01), Curatolo et al.
patent: 5631004 (1997-05-01), Cagle et al.
patent: 5646151 (1997-07-01), Kruse et al.
patent: 0126684 (1984-11-01), None
patent: 0142426 (1985-05-01), None
patent: 0298650 (1989-01-01), None
patent: 0445743 (1991-09-01), None
patent: 0467331 (1992-01-01), None
patent: 0677530 (1995-10-01), None
patent: 0679400 (1995-11-01), None
patent: 0879823 (1998-11-01), None
patent: 0925789 (1999-06-01), None
patent: 11240838 (1999-09-01), None
patent: WO8901772 (1989-03-01), None
patent: 9509601 (1995-04-01), None
patent: WO9509601 (1995-04-01), None
patent: 9619489 (1996-06-01), None
patent: 9620010 (1996-07-01), None
patent: WO9817280 (1998-04-01), None
Robert E. Leonard II, Carol L. Karp, and Eduardo C. Alfonso, Erythromycin, Clarithromycin, and Azithromycin, 1997, Textbook of Ocular Pharmacology, pp. 515-523.
Robert H. Cross, Gary N. Holland, Samuel J. Elias and Rachel Tuz, Corneal Pharmacokinetics of Topical Clarithromycin, Apr. 1995, Investigative Ophthalmology & Visual Science, vol. 36, No. 5, pp. 965-968.
Citation 1: Ophthalmology, vol. 103, p. 842-846, 1996.
Citation 2: Merck Manual No. 16, (Yugengaisha), Medicial Book Service May 1, 1995, p. 2266-2267.
Citation 3: New Edition Diseases and Drugs, Kabushiki Kaisha Yakujinippousha, Jun. 15, 1986, p. 583-594.
Translation of pertinent passages of Citation 2.
Translation of pertinent passages of Citation 3.
First Meeting of the WHO Alliance For The Global Elimination of Trachoma, Geneva, Jun. 30-Jul. 1, 1997, Room A (Main Building).
Jaruratanasirikul, Sutep et al, “Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye”, Antimicrob. Agents Chemother., 1996, 40, 825-6, XP002098516.
Bailey RI et al: “Randomised controlled trial of single-dose azithromycin in treatment of trachoma.”, Lancet, Aug. 21, 1993, 342, p453-6, XP002098517.
Thylefors B. “Azithromycin A new opportunity for control of trachoma”, Who Drug Informaion, 132-133, XP002098518.
Benson Gregg C.
Liu Lance Y.
Peselev Elli
Pfizer Inc.
Richardson Peter C.
LandOfFree
Method of treating eye infections with azithromycin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating eye infections with azithromycin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating eye infections with azithromycin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3448090